Cardiology

doi: 10.25005/2074-0581-2020-22-3-383-389
SOME FEATURES OF PERIPHERAL BLOOD COMPOSITION IN PATIENTS WITH CORONARY ARTERY DISEASE AND ARTERIAL HYPERTENSION

V.G. Mamedova1,2

1Medical Institution of the Ministry of Justice of the Republic of Azerbaijan, Baku, Republic of Azerbaijan
2Azerbaijan State Advanced Training Institute for Doctors named after A. Aliyev, Baku, Republic of Azerbaijan

Objective: To study some parameters of peripheral blood depending on changes of echocardiographic indicators reflecting the presence of myocardial hypoxia in patients with coronary artery disease (CAD), arterial hypertension (AH), and in their combination.

Methods: Examined 98 men at the age of 45 to 70 years, suffering from various clinical forms of CAD (n=41), stage I-III AH (n=35), and a combination of CAD and AH (n=22). The disease variants were spread as follows: acute myocardial infarction (n=4), atherosclerotic (n=9), post-infarction (n=5) cardiosclerosis, unstable (n=1), stable angina II-III functional classes (FC) (n=6), heart failure II-III FC (n=4), type 2 diabetes (n=4) patients. In all surveyed patients was taken the blood sampling from a vein in the morning on an empty stomach to obtain serum. The study program included cardiac echo with an assessment of standard parameters. The LV mass (LVM) was determined using the Penn Convention formula. The obtained volume indicators were indexed in relation to the surface area of the body, calculating the LV mass index (LVMI).

Results: In patients with CAD and with combined CAD and AH in comparison with patients with AH (without CAD) indicators of LVM and LVMI were comparatively lower (due to high blood pressure), though they more often revealed the cases of segmental LV hypokinesis and diastolic dysfunction of the LV. It could be partly due to the changes of morphofunctional properties of erythrocytes, the presence of a chronic inflammatory response, and the worsening of coagulation and rheological properties of peripheral blood.

Conclusions: In patients with CAD and a combination of CAD and AH, in comparison with patients with AH (in the absence of CAD), there is increased deformability of erythrocytes, availability of indicators attesting the reaction of chronic inflammation, and a large degree of pathological changes in the rheological properties of blood.

Keywords: Coronary artery disease, arterial hypertension, blood cells, chronic sluggish inflammation, coagulation properties of blood, dyslipidemia.

Download file:


References
  1. Moreno-Viedma V, Amor M, Sarabi A, Bilban M, Staffler G, Zeyda M, et al. Common dysregulated pathways in obese adipose tissue and atherosclerosis. Cardiovasc Diabetol. 2016;15(1):120.
  2. Velkov VV. Ts-reaktivnyy belok i lipoprotein assotsiirovannaya fosfolipaza A2: novye fakty i novye vozmozhnosti dlya diagnostiki i stratifikatsii serdechno- sosudistykh riskov [C-reactive protein and lipoproteinassociated phospholipase A2: new facts and new opportunities for the diagnosis and stratification of cardiovascular risks]. Poliklinika. 2010;1:18-21.
  3. Ford TJ, Corcoran D, Berry C. Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need. BMJ Heart. 2018;104:284-92. Available from: https://doi.org/10.1136/heartjnl-2017-311446
  4. Buttet M, Traynard V, Tran TT, Besnard P, Poirier H, Niot I. From fatty-acid sensing to chylomicron synthesis: role of intestinal lipid-binding proteins. Biochimie. 2014;96:37-47. Available from: https://doi.org/10.1016/j.biochi. 2013.08.011
  5. Ruf RR. Rol’ vospaleniya v razvitii ateroskleroza i serdechno-sosudistykh sobytiy [The role of inflammation in the development of atherosclerosis and cardiovascular events]. Sibirskoe meditsinskoe obozrenie. 2015;6:23-9.
  6. Chazova EI, Zhernakova YuV (ot imeni ekspertov). Klinicheskie rekomen-datsii. Diagnostika i lechenie arterial’noy gipertonii [Clinical recommendations. Diagnostics and treatment of arterial hypertension]. Sistemnye gipertenzii. 2019;16(1):6-31. Available from: https://doi.org/10.26442/207508 2X.2019.1.190179
  7. Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32:1769-818.
  8. Flakskampf FA, Sandrikov VA. (red) Prakticheskaya ekhokardiografiya (rukovodstvo po ekhokardiograficheskoy diagnostike). Vtoroe izdanie [Practical echocardiography]. Moscow, RF: MEDpress-inform; 2019. 843 p.
  9. Kawel-Boehm N, Kronmal R, Eng J, Folsom A, Burke G, Carr JJ, et al. Left ventricular mass at MRI and long-term risk of cardiovascular events: the Multi-Ethnic Study of Atherosclerosis (MESA). Radiology.2019;293(1):107-14. Available from: https://doi.org/10.1148/radiol.2019182871
  10. Pozdnyakova NV, Petrushin IA, Tatarchenko IP, Mordovina AG. Arteri-al’naya gipertoniya: vozmozhnosti korrektsii strukturno-funktsional’nogo remodelirovaniya serdtsa i sosudov [Arterial hypertension: possibilities of correction of structural and functional remodeling of the heart and blood vessels]. Funktsional’naya diagnostika. 2011;3:15-21.
  11. Cuocolo R, Ponsiglione A, Dell’Aversana S, D’Acierno L, Lassandro G, Ugga L. The cardiac conundrum: a systematic review and bibliometric analysis of authorship in cardiac magnetic resonance imaging studies. Insights Imaging. 2020;11(1):42. Available from: https://doi.org/10.1186/s13244-020-00850-1
  12. Orlova NN. Aktivnost’ svobodnoradikal’nykh okislitel’nykh reaktsiy i sostoyanie lipidnogo obmena pri gipertonicheskoy bolezni [Activity of free-radical oxidative reactions and state of lipid metabolism in hypertensive disease]. Ukrainskiy kardiologicheskiy zhurnal. 2009;5:56-60.
  13. Billakh KhM, Khasanov NR, Oslopov VN, Chugunova DN. Membrannye narusheniya kak osnova dislipidemii i arterial’noy gipertonii [Membrane disorders as a basis for dyslipidemia and arterial hypertension]. Prakticheskaya meditsina. 2013;3:34-6.
  14. Shen J, Zhang J, Wen J, Ming Q, Zhang J, Xu Y. Correlation of serum alanine aminotransferase and aspartate aminotransferase with coronary heart disease. Int J Clin Exp Med. 2015;8(3):4399-404.
  15. Lopez-Candales A, Hernández Burgos PM, Hernandez-Suarez DF, Harris D. Linking chronic inflammation with cardiovascular disease: from normal aging to the metabolic syndrome. J Nat Sci. 2017;3(4):341.
  16. Petelina TI, Musikhina NA, Gapon LI, Sharoyan YuA, Gorbatenko EA, Zueva EV. Sravnitel’nyy analiz dannykh prospektivnogo issledovaniya biokhimicheskikh parametrov syvorotki krovi u bol’nykh ishemicheskoy bolezn’yu serdtsa s nalichiem i otsutstviem sakharnogo diabeta 2 tipa [Comparative analysis of data from a prospective study of blood serum biochemical parameters in patients with ischemic heart disease with or without type 2 diabetes]. Ural’skiy meditsinskiy zhurnal. 2018;7:72-8.
  17. Filatova OV, Agarkova SA. Reologicheskie svoystva krovi v zavisimo-sti ot vozrasta i pola [Rheological properties of blood depending on age and gender]. Fiziologiya cheloveka. 2015;41(4):110-8.
  18. Chen G, Liu YW, Zhao L, Liao F. Regulation of blood viscosity in disease prevention and treatment. Chin Sci Bull. 2012;57(16):1946-52. Available from: https://doi.org/10.1007/s11434-012-5165-4
  19. Ciuffetti G, Schillaci G, Lombardini R, Pirro M, Vaudo G, Mannarino E. Prognostic impact of low-shear whole blood viscosity in hypertensive men. Eur J Clin Invest. 2005;35:93-8. Available from: https://doi.org/10.1111/j.1365- 2362.2005.01437.x
  20. Nozirov JKh, Akhmedov A, Rahimov Z. Rasprostranyonnost’ ishemicheskoy bolezni serdtsa i eyo modifitsiruemykh faktorov riska sredi zhiteley sel’skikh gornykh rayonov [Ischemic heart disease prevalence and its modified risk factors among the inhabitants of the rural alpine areas]. Zdravookhranenie Tadzhikistana. 2012;1:29-32.
  21. Boytsov SA, Bolotova EV, Samorodskaya IV, Inozemtsev ES. Vzaimosvyaz’ regional’nykh urovney smertnosti ot ishemicheskoy bolezni serdtsa s sotsial’no- ekonomicheskimi faktorami v Rossiyskoy Federatsii [The relationship between regional levels of mortality of ischemic heart disease and social economic factors in the Russian Federation]. Problemy sotsial’noy gigieny, zdravookhraneniya i istorii meditsiny. 2016;24(2):68-73. Available from: https://doi.org/10.1016/0869-866X-2016-24-2-68-73
  22. Nurpolatova ST. Osobennosti techeniya ishemicheskoy bolezni serdtsa na fone anemii razlichnoy etiologii [Features of the course of coronary artery disease against the background of anemia of various etiologies]. Biologiya i integrativnaya meditsina. 2016;1:59-63.
  23. Sidaruk SP, Petrova EB, Mitkovskaya NP. Anemiya pri serdechno-sosudistykh zabolevaniyakh [Anemia in cardiovascular diseases]. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski. 2017;1(1):38-45.
  24. Sadikova KZh, Shalkharova ZhS, Shalkharova ZhN, i dr. Obshchaya vyazkost’ krovi i lipidnyy profil’ [Common blood viscosity and lipid profile]. Medicine. 2016;5:78-82.

Authors informations:

Mamedova Vusala Gazanfarkizi
Cardiologist, Medical Institution of the Ministry of Justice of the Republic of Azerbaijan; Applicant, Azerbaijan State Advanced Training Institute for Doctors named after A. Aliyev
ORCID ID: 0000-0003-0270-8996
E-mail: vusalagaxramankizi@mail.ru

Information about the source of support in the form of grants, equipment, and drugs

The author did not receive financial support from manufacturers of medicines and medical equipment

Conflict of interest: No conflict

Address for correspondence:

Mamedova Vusala Gazanfarkizi
Cardiologist, Medical Institution of the Ministry of Justice of the Republic of Azerbaijan; Applicant, Azerbaijan State Advanced Training Institute for Doctors named after A. Aliyev

1078, Republic of Azerbaijan, Baku, J. Mamedqulizade str., 201

Tel.: +994 (706) 862860

E-mail: vusalagaxramankizi@mail.ru

Materials on the topic: